301089SZSE

Tuo Xin Pharmaceutical Co., Ltd.

拓新药业

301089

Shenzhen Stock Exchange

44 announcements tracked· Last: August 9, 2026

Key Financials

Revenue¥92.5M

Net Profit-¥10.5M

ROE-0.71%

Debt Ratio10.66%

Monetary Funds¥115.7M

Receivables¥45.5M

Total Shares126.5M

Announcements

44 totalCSV

Notes & Comments

Sign in to leave a comment or private note.

No notes or comments yet.